0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letters to the Editor   |    
Discrepancy in Response and Remission Rates for SAMe-Treated Patients in a Double-Blind, Randomized Clinical Trial
Sheryl B. Fleisch, M.D.; Michael J. Travis, M.D.; Neil D. Ryan, M.D.
Am J Psychiatry 2010;167:1533-1533. doi:10.1176/appi.ajp.2010.10091252
View Author and Article Information
Pittsburgh, PA.

The authors report no financial relationships with commercial interests.

This letter was accepted for publication in September 2010.

Accepted September , 2010.

Copyright © American Psychiatric Association

To the Editor: In the August 2010 issue of the Journal, George I. Papakostas, M.D., et al. (1), appear to have inadvertently made a calculation error, which has affected the results of their data. The authors stated that "response rates for SAMe-treated patients versus placebo-treated patients were 36.1% versus 17.6%, respectively, while remission rates were 25.8% versus 11.7%, respectively" (1, p. 946).

Our calculations, based on the data presented in the article, are inconsistent with the aforementioned percentages. The quoted percentage is 36.1% for SAMe plus antidepressant treatment among responders, whereas the actual number of responders indicated on page 945 is 18/39, or 46.1%. Likewise, the quoted percentage for SAMe plus antidepressant treatment among patients who remitted is 25.8%, whereas the actual number of these patients cited on page 945 is 14/39, or 35.8%. Interestingly, Figure 2 appears to correspond with our calculations rather than the percentages cited in the article. We believe that 36.1% was given instead of 46.1% and 25.8% instead of 35.8%. Furthermore, we believe the alteration in these percentages would affect the number needed to treat.

We would be grateful if the authors could clarify the results of this thought-provoking study.

Papakostas  GI;  Mischoulon  D;  Shyu  I;  Alpert  JE;  Fava  M:  S-Adenosyl methionine (SAME) augmentation of serotonin reup-take inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.  Am J Psychiatry 2010; 167: 942—948
[CrossRef] | [PubMed]
 
References Container
+

References

Papakostas  GI;  Mischoulon  D;  Shyu  I;  Alpert  JE;  Fava  M:  S-Adenosyl methionine (SAME) augmentation of serotonin reup-take inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.  Am J Psychiatry 2010; 167: 942—948
[CrossRef] | [PubMed]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 9.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 1.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 1.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 4.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 57.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
APA Guidelines
PubMed Articles